[Federal Register Volume 86, Number 126 (Tuesday, July 6, 2021)]
[Notices]
[Pages 35499-35504]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14259]


=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPPT-2019-0578; FRL-10004-31]


Approvals and Denials of Test Marketing Exemptions for Certain 
New Chemicals Under TSCA

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This document provides notification of EPA's approvals and 
denials of applications for test marketing exemptions (TMEs) submitted 
under the Toxic Substances Control Act (TSCA) for certain new 
chemicals. The test marketing conditions are described in the TME 
applications and in this document.

FOR FURTHER INFORMATION CONTACT: For technical information contact: Meg 
Victor, New Chemicals Division (7405M), Office of Pollution Prevention 
and Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, 
Washington, DC 20460-0001; telephone number: (202) 343-9193; email 
address: <a href="/cdn-cgi/l/email-protection#7b0d12180f140955161e1c3b1e0b1a551c140d"><span class="__cf_email__" data-cfemail="2d5b444e59425f0340484a6d485d4c034a425b">[email protected]</span></a>.
    For general information contact: The TSCA-Hotline, ABVI-Goodwill, 
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 
554-1404; email address: <a href="/cdn-cgi/l/email-protection#efbbbcacaec2a7809b8386818aaf8a9f8ec1888099"><span class="__cf_email__" data-cfemail="37636474761a7f58435b5e59527752475619505841">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

    This action may be of interest to the chemical manufacturers and/or 
importers who submitted the TMEs to EPA and to the public in general. 
The Agency has not attempted to describe all the specific entities that 
may be affected by this action.

B. How can I get copies of this document and other related information?

    The docket for this action, identified by docket identification 
(ID) number EPA-HQ-OPPT-2019-0578, is available at http://www.regulations.gov or at the Office of Pollution Prevention and Toxics 
Docket (OPPT Docket), Environmental Protection Agency Docket Center 
(EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334, 1301 
Constitution Ave. NW, Washington, DC. The Public Reading Room is open 
from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal 
holidays. The telephone number for the Public Reading Room is (202) 
566-1744, and the telephone number for the OPPT Docket is (202) 566-
0280.
    Please note that due to the public health emergency the EPA Docket 
Center (EPA/DC) and Reading Room was closed to public visitors on March 
31, 2020. Our EPA/DC staff will continue to provide customer service 
via email, phone, and webform. For further information on EPA/DC 
services, docket contact information and the current status of the EPA/
DC and Reading Room, please visit https://www.epa.gov/dockets.

II. What is the Agency's authority for taking this action?

    TSCA section 5(h)(1) authorizes EPA to exempt persons from 
premanufacture notification (PMN) requirements and permit them to 
manufacture (which includes import) new chemicals for test marketing 
purposes, if the Agency finds that the manufacture, processing, 
distribution in commerce, use, and disposal of the chemicals for test 
marketing purposes will not present any unreasonable risk of injury to 
health or the environment, including an unreasonable risk to a 
potentially exposed or susceptible subpopulation identified by the 
Administrator for the specific conditions of use identified in the 
applications. The requirement to consider risks to a potentially 
exposed or susceptible subpopulation was added to TSCA section 5(h)(1) 
in 2016. EPA's regulations implementing TSCA section 5(h)(1) are found 
at 40 CFR 720.38.
    TSCA section 5(h)(6) requires EPA to publish in the Federal 
Register notice of receipt of an application for a TME and of the 
disposition of the application. The implementing regulation (40 CFR 
720.38(d)) indicates that EPA will publish a notice in the Federal 
Register explaining the reasons for approval or denial.

III. What action is the Agency taking?

    EPA is publishing this document to announce TME approvals and 
denials. EPA determined that test marketing the new chemicals, under 
the conditions in the TME applications, will not present any 
unreasonable risk of injury to health or the environment; the Agency 
approved the TMEs listed in Unit IV. For those TMEs for which EPA made 
this approval after TSCA was amended in June 2016 by the Lautenberg 
Chemical Safety for the 21st Century Act, EPA's determination included 
an assessment of unreasonable risk to a potentially exposed or 
susceptible subpopulation identified by the Agency for the specific 
conditions of use identified in the applications.
    EPA has denied the following TMEs because EPA was unable to 
determine that test marketing the new chemicals, under the conditions 
in the TME applications will not present any unreasonable risk of 
injury to health or the environment. For those TMEs for which EPA made 
this denial after TSCA was amended in June 2016, EPA's determination 
included an assessment of unreasonable risk to a potentially exposed or 
susceptible subpopulation identified by the Agency for the specific 
conditions of use identified in the applications.

TME-13-0004

    Date of Receipt: November 26, 2012.
    Notice of Receipt: December 26, 2012 (77 FR 76029; FRL-9373-1).

TME-13-0091

    Date of Receipt: August 22, 2013.
    Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).

TME-16-0004

    Date of Receipt: November 3, 2015.
    Notice of Receipt: January 12, 2016 (81 FR 1415; FRL-9940-47).

TME-16-0005

    Date of Receipt: November 3, 2015.
    Notice of Receipt: January 12, 2016 (81 FR 1415; FRL-9940-47).

TME-16-0013

    Date of Receipt: December 15, 2015.
    Notice of Receipt: February 11, 2016 (81 FR 7337; FRL-9942-09).

TME-16-0014

    Date of Receipt: December 15, 2015.
    Notice of Receipt: February 11, 2016 (81 FR 7337; FRL-9942-09).

TME-16-0015

    Date of Receipt: December 15, 2015.
    Notice of Receipt: February 11, 2016 (81 FR 7337; FRL-9942-09).

TME-17-0002

    Date of Receipt: November 17, 2016.
    Notice of Receipt: N/A.

TME-17-0003

    Date of Receipt: April 5, 2017.
    Notice of Receipt: July 7, 2017 (82 FR 31598; FRL-9962-98).

TME-17-0004

    Date of Receipt: April 5, 2017.
    Notice of Receipt: July 7, 2017 (82 FR 31598; FRL-9962-98).

[[Page 35500]]

TME-17-0005

    Date of Receipt: April 5, 2017.
    Notice of Receipt: July 7, 2017 (82 FR 31598; FRL-9962-98).

TME-17-0006

    Date of Receipt: April 5, 2017.
    Notice of Receipt: July 7, 2017 (82 FR 31598; FRL-9962-98).

TME-17-0007

    Date of Receipt: April 5, 2017.
    Notice of Receipt: July 7, 2017 (82 FR 31598; FRL-9962-98).

TME-17-0008

    Date of Receipt: April 5, 2017.
    Notice of Receipt: July 7, 2017 (82 FR 31598; FRL-9962-98).

TME-17-0009

    Date of Receipt: April 13, 2017.
    Notice of Receipt: July 7, 2017 (82 FR 31598; FRL-9962-98).

TME-17-0010

    Date of Receipt: April 13, 2017.
    Notice of Receipt: July 7, 2017 (82 FR 31598; FRL-9962-98).

TME-17-0011

    Date of Receipt: April 13, 2017.
    Notice of Receipt: July 7, 2017 (82 FR 31598; FRL-9962-98).

TME-17-0012

    Date of Receipt: April 19, 2017.
    Notice of Receipt: July 7, 2017 (82 FR 31598; FRL-9962-98).

TME-17-0013

    Date of Receipt: April 19, 2017.
    Notice of Receipt: July 7, 2017 (82 FR 31598; FRL-9962-98).

TME-18-0002

    Date of Receipt: January 26, 2018.
    Notice of Receipt: May 24, 2018 (83 FR 24110; FRL-9977-48).

IV. What restrictions apply to the approved TMEs?

    The test market time period, production volume, number of 
customers, and use must not exceed specifications in the applications. 
All other conditions and restrictions described in the applications and 
in this document must also be met.

TME-12-0009

    Date of Receipt: April 18, 2012.
    Notice of Receipt: N/A.
    Applicant: CBI.
    Chemical: (Generic) Alkyl thiol, manuf. of, by-products from, 
distn. lights.
    Use: (Generic) Intermediate in the production of a commercial 
product.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-12-0010

    Date of Receipt: April 18, 2012.
    Notice of Receipt: N/A.
    Applicant: CBI.
    Chemical: (Generic) alkyl thiol, manuf. of, by-products from, 
distn. lights.
    Use: (Generic) Intermediate in the production of a commercial 
product.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-12-0014

    Date of Receipt: August 27, 2012.
    Notice of Receipt: October 10, 2012 (77 FR 61600; FRL-9363-2).
    Applicant: Cytec Industries, Inc.
    Chemical: (Generic) Substituted heteromonocycle, polymer with 
substituted alkane and substituted alkanediol, alkanoic acid 
substituted ester and substituted heteromonocyle homopolymer.
    Use: Coating resin.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: Forty-five days, commencing on first day of 
commercial manufacture.

TME-13-0001

    Date of Receipt: October 22, 2012.
    Notice of Receipt: December 14, 2012 (77 FR 74473; FRL-9338-5).
    Applicant: Cytec Industries, Inc.
    Chemical: (Generic) Alkenoic acid, ester with alkylpolyol, polymer 
with disubstituted alkane.
    Use: (Generic) Coating resin.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: Forty-five days, commencing on first day of 
commercial manufacture.

TME-13-0002

    Date of Receipt: November 1, 2012.
    Notice of Receipt: December 26, 2012 (77 FR 76029; FRL-9373-1).
    Applicant: Cytec Industries, Inc.
    Chemical: (Generic) Alkenenitrile, polymer with alkadiene, 
substituted alkyl-terminated, polymers with substituted 
carbonomocycles, alkoxy-terminated-substituted alkyl-alkadiene polymer, 
substituted carbomonocycle and halogen substituted carbomonocycle.
    Use: (Generic) Resin for non-dispersive use.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: Forty-five days, commencing on first day of 
commercial manufacture.

TME-13-0003

    Date of Receipt: November 12, 2012.
    Notice of Receipt: December 26, 2012 (77 FR 76029; FRL-9373-1).
    Applicant: Cytec Industries, Inc.
    Chemical: (Generic) Alkenoic acid, reaction product with 
alkylpolyol, polymers with substituted heteromonocycle.
    Use: (Generic) Coating resin.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: Forty-five days, commencing on first day of 
commercial manufacture.

TME-13-0007

    Date of Receipt: January 31, 2013.
    Notice of Receipt: March 22, 2013 (78 FR 17656; FRL-9380-1).
    Applicant: H.B. Fuller Company.
    Chemical: (Generic) Fatty acids, C18-unsatd., dimers, polymers with 
alkane acid, 1,6-hexanediol, 1,1'-methylenebis[4-isocyanatobenzene] and 
neopentyl glycol.
    Use: (Generic) Industrial adhesive.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-13-0008

    Date of Receipt: February 19, 2013.
    Notice of Receipt: May 15, 2013 (78 FR 28586; FRL-9383-9).
    Applicant: Cytec Industries, Inc.
    Chemical: (Generic) Alkenoic acid, polymer with alkadiene and 
alkenenitrile, substituted alkyl-terminated, polymers with substituted 
carbomonocycles, alkoxy-terminated-substituted alkyl-alkadiene polymer, 
substituted carbomonocycle and halogen substituted carbomonocycle.
    Use: (Generic) Resin for non-dispersive uses.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: Forty-five days, commencing on first day of 
commercial manufacture.

TME-13-0009

    Date of Receipt: February 19, 2013.
    Notice of Receipt: May 15, 2013 (78 FR 28586; FRL-9383-9).
    Applicant: CBI.
    Chemical: (Generic) Furandione derivative reaction products.
    Use: (Generic) Production aid in refinery operations.

[[Page 35501]]

    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-13-0010

    Date of Receipt: May 6, 2013.
    Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
    Applicant: CBI.
    Chemical: (Generic) Alpha-olefins, polymers with maleic anhydride, 
alkyl esters.
    Use: (Generic) Crude oil additive.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-13-0053

    Date of Receipt: August 14, 2013.
    Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
    Applicant: CBI.
    Chemical: (Generic) Amine capped fatty acid dimer polyamide.
    Use: (Generic) Component in drilling fluids; (Generic) Component in 
resin coatings.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-13-0054

    Date of Receipt: August 7, 2013.
    Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
    Applicant: CBI.
    Chemical: (Generic) Cycloalkylamino oleylalkyl alkylamide acid 
salt.
    Use: (Generic) Inhibitor for oil field applications.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-13-0055

    Date of Receipt: August 7, 2013.
    Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
    Applicant: CBI.
    Chemical: (Generic) Cycloalkylamino oleylalkyl alkylamide acid 
salt.
    Use: (Generic) Inhibitor for oil field applications.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-13-0056

    Date of Receipt: August 7, 2013.
    Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
    Applicant: CBI.
    Chemical: (Generic) Cycloalkylamino oleylalkyl alkylamide acid 
salt.
    Use: (Generic) Inhibitor for oil field applications.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-13-0057

    Date of Receipt: August 7, 2013.
    Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
    Applicant: CBI.
    Chemical: (Generic) Cycloalkylamino oleylalkyl alkylamide acid 
salt.
    Use: (Generic) Inhibitor for oil field applications.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-13-0058

    Date of Receipt: August 7, 2013.
    Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
    Applicant: CBI.
    Chemical: (Generic) Cycloalkylamino oleylalkyl alkylamide acid 
salt.
    Use: (Generic) Inhibitor for oil field applications.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-13-0059

    Date of Receipt: August 7, 2013.
    Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
    Applicant: CBI.
    Chemical: (Generic) Cycloalkylamino oleylalkyl alkylamide acid 
salt.
    Use: (Generic) Inhibitor for oil field applications.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-13-0060

    Date of Receipt: August 12, 2013.
    Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
    Applicant: CBI.
    Chemical: (Generic) Cycloalkylamino cocoalkyl alkylamide acid salt.
    Use: (Generic) Inhibitor for oil field applications.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-13-0061

    Date of Receipt: August 12, 2013.
    Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
    Applicant: CBI.
    Chemical: (Generic) Cycloalkylamino cocoalkyl alkylamide acid salt.
    Use: (Generic) Inhibitor for oil field applications.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-13-0062

    Date of Receipt: August 12, 2013.
    Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
    Applicant: CBI.
    Chemical: (Generic) Cycloalkylamino cocoalkyl alkylamide acid salt.
    Use: (Generic) Inhibitor for oil field applications.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-13-0063

    Date of Receipt: August 12, 2013.
    Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
    Applicant: CBI.
    Chemical: (Generic) Cycloalkylamino cocoalkyl alkylamide acid salt.
    Use: (Generic) Inhibitor for oil field applications.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-13-0064

    Date of Receipt: August 12, 2013.
    Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
    Applicant: CBI.
    Chemical: (Generic) Cycloalkylamino cocoalkyl alkylamide acid salt.
    Use: (Generic) Inhibitor for oil field applications.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-13-0065

    Date of Receipt: August 12, 2013.
    Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
    Applicant: CBI.

[[Page 35502]]

    Chemical: (Generic) Cycloalkylamino cocoalkyl alkylamide acid salt.
    Use: (Generic) Inhibitor for oil field applications.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-14-0002

    Date of Receipt: January 10, 2014.
    Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
    Applicant: CBI.
    Chemical: (Generic) Modified essential oil.
    Use: (Generic) Highly dispersive use.
    Production Volume: CBI.
    Number of Customers: CBI
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-14-0003

    Date of Receipt: March 7, 2014.
    Notice of Receipt: June 9, 2014 (79 FR 32939; FRL-9910-70).
    Applicant: CBI.
    Chemical: (Generic) Substituted acid, electrophilic aromatic 
substitution products.
    Use: (Generic) Foam suppressant.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-14-0004

    Date of Receipt: July 3, 2014.
    Notice of Receipt: N/A.
    Applicant: Clean Chemistry.
    Chemical: (Generic) Organic peroxide.
    Use: Water clarifying agent, odor control agent, bleaching agent, 
and general oxidant for water treatment; (Generic) Destructive use in 
fuel production.
    Production Volume: CBI.
    Number of Customers: Six.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-15-0001

    Date of Receipt: November 21, 2014.
    Notice of Receipt: N/A.
    Applicant: Industrial Specialty Chemicals.
    Chemical: CBI.
    Use: Paint detackification.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-15-0004

    Date of Receipt: January 8, 2015.
    Notice of Receipt: March 19, 2015 (80 FR 14374; FRL-9924-61).
    Applicant: CBI.
    Chemical: (Generic) Alkylaminopropanamide, N-[dialkylamino-propyl], 
salt.
    Use: (Generic) Oil production.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-15-0005

    Date of Receipt: January 8, 2015.
    Notice of Receipt: March 19, 2015 (80 FR 14374; FRL-9924-61).
    Applicant: CBI.
    Chemical: (Generic) Alkylaminopropanamide, N-[dialkylamino-propyl], 
salt.
    Use: (Generic) Oil production.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-15-0006

    Date of Receipt: January 8, 2015.
    Notice of Receipt: March 19, 2015 (80 FR 14374; FRL-9924-61).
    Applicant: CBI.
    Chemical: (Generic) Alkylaminopropanamide, N-[dialkylamino-propyl], 
salt.
    Use: (Generic) Oil production.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-15-0007

    Date of Receipt: January 8, 2015.
    Notice of Receipt: March 19, 2015 (80 FR 14374; FRL-9924-61).
    Applicant: CBI.
    Chemical: (Generic) Alkylaminopropanamide, N-[dialkylamino-propyl], 
salt.
    Use: (Generic) Oil production.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-15-0008

    Date of Receipt: March 20, 2015.
    Notice of Receipt: April 22, 2015 (80 FR 22512; FRL-9926-36).
    Applicant: CBI.
    Chemical: (Generic) Alkyl substituted cresol.
    Use: (Generic) Intermediate.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-15-0011

    Date of Receipt: June 24, 2015.
    Notice of Receipt: August 14, 2015 (80 FR 48855; FRL-9931-82).
    Applicant: CBI.
    Chemical: (Generic) Dialkylamino alkylamide salt.
    Use: (Generic) Oil production.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-15-0012

    Date of Receipt: June 24, 2015.
    Notice of Receipt: August 14, 2015 (80 FR 48855; FRL-9931-82).
    Applicant: CBI.
    Chemical: (Generic) Dialkylamino alkylamide salt.
    Use: (Generic) Oil production.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-15-0013

    Date of Receipt: June 24, 2015.
    Notice of Receipt: August 14, 2015 (80 FR 48855; FRL-9931-82).
    Applicant: CBI.
    Chemical: (Generic) Dialkylamino alkylamide salt.
    Use: (Generic) Oil production.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-15-0014

    Date of Receipt: June 24, 2015.
    Notice of Receipt: August 14, 2015 (80 FR 48855; FRL-9931-82).
    Applicant: CBI.
    Chemical: (Generic) Dialkylamino alkylamide salt.
    Use: (Generic) Oil production.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-16-0001

    Date of Receipt: November 2, 2015.
    Notice of Receipt: January 12, 2016 (81 FR 1415; FRL-9940-47).
    Applicant: CBI.
    Chemical: (Generic) Dialkylamino alkylamide salt.
    Use: (Generic) Oil production.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

[[Page 35503]]

TME-16-0002

    Date of Receipt: November 2, 2015.
    Notice of Receipt: January 12, 2016 (81 FR 1415; FRL-9940-47).
    Applicant: CBI.
    Chemical: (Generic) Dialkylamino alkylamide salt.
    Use: (Generic) Oil production.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-16-0003

    Date of Receipt: November 3, 2015.
    Notice of Receipt: January 12, 2016 (81 FR 1415; FRL-9940-47).
    Applicant: CBI.
    Chemical: (Generic) Beta amino fatty ester.
    Use: Chemical Intermediate.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-16-0006

    Date of Receipt: November 3, 2015.
    Notice of Receipt: January 12, 2016 (81 FR 1415; FRL-9940-47).
    Applicant: CBI.
    Chemical: (Generic) Dialkylamino alkylamide.
    Use: Chemical Intermediate.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-16-0007

    Date of Receipt: November 10, 2015.
    Notice of Receipt: N/A.
    Applicant: CBI.
    Chemical: (Generic) Poly alkylimidazoline.
    Use: (Generic) Emulsifier.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-16-0008

    Date of Receipt: November 10, 2015.
    Notice of Receipt: N/A.
    Applicant: CBI.
    Chemical: (Generic) Poly alkylimidazoline.
    Use: (Generic) Emulsifier.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-16-0009

    Date of Receipt: November 10, 2015.
    Notice of Receipt: N/A.
    Applicant: CBI.
    Chemical: (Generic) Poly alkylimidazoline.
    Use: (Generic) Emulsifier.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-16-0010

    Date of Receipt: November 10, 2015.
    Notice of Receipt: N/A.
    Applicant: CBI.
    Chemical: (Generic) Poly alkylimidazoline.
    Use: (Generic) Emulsifier.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-16-0011

    Date of Receipt: November 10, 2015.
    Notice of Receipt: N/A.
    Applicant: CBI.
    Chemical: (Generic) Poly alkylimidazoline.
    Use: (Generic) Emulsifier.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-16-0012

    Date of Receipt: November 10, 2015.
    Notice of Receipt: N/A.
    Applicant: CBI.
    Chemical: (Generic) Poly alkylimidazoline.
    Use: (Generic) Emulsifier.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-16-0016

    Date of Receipt: December 16, 2015.
    Notice of Receipt: February 11, 2016 (81 FR 7337; FRL-9942-09).
    Applicant: CBI.
    Chemical: (Generic) Dialkylamino alkylamide inner salt.
    Use: (Generic) Oil production.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-16-0017

    Date of Receipt: May 25, 2016.
    Notice of Receipt: July 29, 2016 (81 FR 49976; FRL-9949-63) and 
September 6, 2017 (82 FR 42088; FRL-9965-05).
    Applicant: CBI.
    Chemical: (Generic) Modified vegetable oil.
    Use: (Generic) Wax.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-18-0001

    Date of Receipt: November 16, 2017.
    Notice of Receipt: May 22, 2018 (83 FR 23671; FRL-9972-08).
    Applicant: CBI.
    Chemical: (Generic) Renewable naptha.
    Use: Component in automotive gasoline/transportation fuel for 
consumer use.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.

TME-18-0003

    Date of Receipt: July 17, 2018.
    Notice of Receipt: October 22, 2018 (83 FR 53241; FRL-9985-20).
    Applicant: CBI.
    Chemical: (Generic) Alkylated diphenylamines, homopolymers.
    Use: (Generic) Additive.
    Production Volume: CBI.
    Number of Customers: CBI.
    Test Marketing Period: CBI days, commencing on first day of 
commercial manufacture.
    EPA may impose restrictions considered appropriate by the Agency on 
test marketing activities and may modify or revoke this test marketing 
exemption upon receipt of any information that indicates the test 
marketing activity may present an unreasonable risk of injury to health 
and the environment. The following additional restrictions apply to 
these TMEs: A bill of lading accompanying each shipment must state that 
the use of the chemical is restricted to that approved in the TME. In 
addition, the applicant shall maintain the following records for 5 
years after the date they are created, and shall make them available 
for inspection or copying in accordance with TSCA section 11:
    1. Records of the quantity of the TME chemical produced and the 
date of manufacture.
    2. Records of dates of the shipments to each customer and the 
quantities supplied in each shipment.
    3. Copies of the bill of lading that accompanies each shipment of 
the TME chemical.

[[Page 35504]]

V. What was EPA's risk assessment for these approved TMEs?

    EPA did not identify unreasonable health or environmental risks for 
the test market chemicals under the intended conditions of use 
described in the TME applications. Therefore, the test market 
activities will not present any unreasonable risk of injury to human 
health or the environment, including an unreasonable risk to a 
potentially exposed or susceptible subpopulation identified by the 
Administrator for the specific conditions of use identified in the 
applications.

VI. Can EPA change its decision on these approved TMEs in the future?

    The Agency reserves the right to rescind approval or modify the 
conditions and restrictions of an exemption upon the receipt or 
evaluation of any information, new or existing, that indicates the test 
marketing activities may present an unreasonable risk of injury to 
human health or the environment.

    Authority: 15 U.S.C. 2601 et seq.

    Dated: June 11, 2021.
Madison Le,
Director, New Chemicals Division, Office of Pollution Prevention and 
Toxics.
[FR Doc. 2021-14259 Filed 7-2-21; 8:45 am]
BILLING CODE 6560-50-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>